HomeCompareSEBC vs JNJ

SEBC vs JNJ: Dividend Comparison 2026

SEBC yields 3.05% · JNJ yields 2.13%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 SEBC wins by $77.6K in total portfolio value
10 years
SEBC
SEBC
● Live price
3.05%
Share price
$28.55
Annual div
$0.87
5Y div CAGR
41.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$107.8K
Annual income
$36,214.86
Full SEBC calculator →
JNJ
Johnson & Johnson
● Live price
2.13%
Share price
$244.44
Annual div
$5.20
5Y div CAGR
28%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.3K
Annual income
$4,689.40
Full JNJ calculator →

Portfolio growth — SEBC vs JNJ

📍 SEBC pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodSEBCJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, SEBC + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
SEBC pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

SEBC
Annual income on $10K today (after 15% tax)
$259.02/yr
After 10yr DRIP, annual income (after tax)
$30,782.63/yr
JNJ
Annual income on $10K today (after 15% tax)
$180.82/yr
After 10yr DRIP, annual income (after tax)
$3,985.99/yr
At 15% tax rate, SEBC beats the other by $26,796.64/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of SEBC + JNJ for your $10,000?

SEBC: 50%JNJ: 50%
100% JNJ50/50100% SEBC
Portfolio after 10yr
$69.1K
Annual income
$20,452.13/yr
Blended yield
29.61%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

SEBC
No analyst data
Altman Z
0.4
Piotroski
4/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
-6.4% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

SEBC buys
0
JNJ buys
0
No recent congressional trades found for SEBC or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricSEBCJNJ
Forward yield3.05%2.13%
Annual dividend / share$0.87$5.20
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR41.7%28%
Portfolio after 10y$107.8K$30.3K
Annual income after 10y$36,214.86$4,689.40
Total dividends collected$80.0K$15.4K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: SEBC vs JNJ ($10,000, DRIP)

YearSEBC PortfolioSEBC Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$11,132$431.80$10,592$272.30+$540.00SEBC
2$12,548$636.55$11,289$357.73+$1.3KSEBC
3$14,376$950.20$12,123$472.89+$2.3KSEBC
4$16,824$1,441.73$13,141$629.86+$3.7KSEBC
5$20,236$2,234.40$14,408$846.81+$5.8KSEBC
6$25,212$3,559.13$16,021$1,151.60+$9.2KSEBC
7$32,849$5,872.26$18,122$1,588.22+$14.7KSEBC
8$45,281$10,132.29$20,930$2,228.20+$24.4KSEBC
9$66,947$18,496.31$24,792$3,191.91+$42.2KSEBC
10$107,848$36,214.86$30,274$4,689.40+$77.6KSEBC

SEBC vs JNJ: Complete Analysis 2026

SEBCStock

Southeastern Banking Corporation operates as a bank holding company for Southeastern Bank that provides commercial and consumer banking products and services in the United States. The company offers checking, savings, and money market accounts, as well as certificates of deposit. It also provides home, construction, personal, auto, boat and recreational vehicle, business term, equipment, and small business administration loans; home equity loans and lines, and operating lines of credit; commercial real estate and residential real estate–mortgage loans, as well as other commercial, financial, and agricultural loans; and debit and credit cards. In addition, the company offers business cash management and overdraft protection services, as well as online and mobile banking, bill payment, and e-statement services. It operates through 10 branch locations and ATM networks in southeast Georgia and northeast Florida. The company was founded in 1888 and is headquartered in Darien, Georgia.

Full SEBC Calculator →

JNJHealthcare

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.

Full JNJ Calculator →
📬

Get this SEBC vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

SEBC vs SCHDSEBC vs JEPISEBC vs OSEBC vs KOSEBC vs MAINSEBC vs ABBVSEBC vs MRKSEBC vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.